• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Priority actions for elevating liver health in Canada: A call to action.提升加拿大肝脏健康的优先行动:行动呼吁。
Can Liver J. 2023 Jul 26;6(2):283-290. doi: 10.3138/canlivj-2022-0041. eCollection 2023 Jul.
2
Tuberculosis结核病
3
4
Risk management frameworks for human health and environmental risks.人类健康与环境风险的风险管理框架。
J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608.
5
Health Care Resource Use and Cost Burden of Chronic Kidney Disease in Patients With Chronic Liver Disease: A Real-World Claims Analysis.慢性肝病患者慢性肾脏病的医疗资源使用及成本负担:一项真实世界索赔分析
Hepatol Commun. 2020 Aug 2;4(10):1404-1418. doi: 10.1002/hep4.1573. eCollection 2020 Oct.
6
Patient-centered care: Key elements applicable to chronic liver disease.以患者为中心的护理:适用于慢性肝脏疾病的关键要素。
Hepatology. 2023 Jul 1;78(1):307-318. doi: 10.1002/hep.32618. Epub 2022 Jul 4.
7
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
8
Association between chronic liver disease and clinical outcomes in out-of-hospital cardiac arrest.院外心脏骤停中慢性肝病与临床结局的关联
Resuscitation. 2021 Jan;158:1-7. doi: 10.1016/j.resuscitation.2020.10.040. Epub 2020 Nov 12.
9
Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag.血小板生成素受体激动剂治疗慢性肝病相关性血小板减少症的研究进展:聚焦阿伐曲泊帕
Clin Med Insights Blood Disord. 2019 Oct 21;12:1179545X19875105. doi: 10.1177/1179545X19875105. eCollection 2019.
10
The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017.非酒精性脂肪性肝病所致残疾负担日益加重:2007 - 2017年全球疾病负担数据
Hepatol Commun. 2020 Sep 14;4(12):1769-1780. doi: 10.1002/hep4.1599. eCollection 2020 Dec.

引用本文的文献

1
Investing in the Future: Training for Clinical Care and Research in Liver Disease.投资未来:肝病临床护理与研究培训
Can Liver J. 2025 Feb 25;8(1):1-4. doi: 10.3138/canlivj-2025-0006. eCollection 2025 Feb.

本文引用的文献

1
What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association.如何应对肝细胞癌:国际肝癌协会给卫生当局的建议
JHEP Rep. 2022 Sep 8;4(12):100578. doi: 10.1016/j.jhepr.2022.100578. eCollection 2022 Dec.
2
Birth cohort hepatitis C antibody prevalence in real-world screening settings in Ontario.安大略省实际筛查环境中出生队列的丙型肝炎抗体流行率。
Can Liver J. 2022 Aug 16;5(3):362-371. doi: 10.3138/canlivj-2021-0036. eCollection 2022 Aug.
3
AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis.美国肝病研究学会实践指南:失代偿期肝硬化的姑息治疗与基于症状的管理
Hepatology. 2022 Sep;76(3):819-853. doi: 10.1002/hep.32378. Epub 2022 Apr 22.
4
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.欧洲肝脏研究学会-《柳叶刀》肝脏委员会:保护下一代欧洲人免受肝脏疾病并发症和过早死亡的影响。
Lancet. 2022 Jan 1;399(10319):61-116. doi: 10.1016/S0140-6736(21)01701-3. Epub 2021 Dec 2.
5
Increasing Incidence of Cirrhosis Over the Past 2 Decades Among Children in Ontario, Canada.在过去的 20 年中,加拿大安大略省儿童肝硬化发病率不断上升。
Am J Gastroenterol. 2022 Jan 1;117(1):189-192. doi: 10.14309/ajg.0000000000001564.
6
Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort.内科住院治疗与肝脏疾病:一项多中心队列的疾病负担比较分析。
Aliment Pharmacol Ther. 2021 Sep;54(5):689-698. doi: 10.1111/apt.16488. Epub 2021 Jun 28.
7
NAFLD and Alcohol-Associated Liver Disease Will Be Responsible for Almost All New Diagnoses of Cirrhosis in Canada by 2040.到 2040 年,非酒精性脂肪性肝病和酒精性肝病将导致加拿大近所有新诊断的肝硬化。
Hepatology. 2021 Dec;74(6):3330-3344. doi: 10.1002/hep.32032. Epub 2021 Aug 15.
8
Global Epidemiology of Chronic Liver Disease.慢性肝病的全球流行病学
Clin Liver Dis (Hoboken). 2021 Jun 4;17(5):365-370. doi: 10.1002/cld.1061. eCollection 2021 May.
9
Trends in indications and outcomes of liver transplantation in Canada: A multicenter retrospective study.加拿大肝移植的适应证及结局趋势:一项多中心回顾性研究。
Transpl Int. 2021 Aug;34(8):1444-1454. doi: 10.1111/tri.13903. Epub 2021 Jul 7.
10
Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.2019-2030 年加拿大非酒精性脂肪性肝病负担:建模研究。
CMAJ Open. 2020 Jun 9;8(2):E429-E436. doi: 10.9778/cmajo.20190212. Print 2020 Apr-Jun.

提升加拿大肝脏健康的优先行动:行动呼吁。

Priority actions for elevating liver health in Canada: A call to action.

作者信息

Brahmania Mayur, Biondi Mia J, Joshi Supriya, Lee Elizabeth, Jung Hsiao-Ming, Kehar Mohit

机构信息

Foothills Hospital, University of Calgary, Calgary, Alberta, Canada.

School of Nursing, York University, Toronto, Ontario, Canada.

出版信息

Can Liver J. 2023 Jul 26;6(2):283-290. doi: 10.3138/canlivj-2022-0041. eCollection 2023 Jul.

DOI:10.3138/canlivj-2022-0041
PMID:37503516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10370728/
Abstract

Chronic liver disease (CLD) has become a silent epidemic in our country and has resulted in significant physical, psychosocial, and financial burden. Although other international liver associations have published frameworks for the principal actions required to improve liver health across health systems, Canada does not have a strategy to address the growing concerns of CLD. Thus, a multidisciplinary group of care providers involved in CLD management in Canada gathered to review the current burden of disease, gaps in management, and key opportunities for improving the identification and management of people at risk of developing progressive CLD.

摘要

慢性肝病(CLD)在我国已成为一种悄无声息的流行病,并造成了巨大的身体、心理社会和经济负担。尽管其他国际肝脏协会已发布了关于在整个卫生系统中改善肝脏健康所需主要行动的框架,但加拿大却没有应对CLD日益增长问题的战略。因此,加拿大参与CLD管理的多学科护理提供者小组齐聚一堂,以审查当前的疾病负担、管理差距以及改善对有发展为进行性CLD风险人群的识别和管理的关键机会。